ADAM10 and lymphoma: In Hodgkin’s lymphoma cells, LT4, CAM29, and MN8 act to reduce the release of ADAM10 substrates (CD30 and TNF-α), lower the ATP content of lymphoma cells, and increase the release of lactate dehydrogenase, ultimately inhibiting the growth and proliferation of lymphoma cells (Pece et al., 2022).